Materialsand Methods
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Precision.
We assessed the precision of the assay by making replicate measurements on a single plate (within  batch) and by duplicate assay on 15 different plates, using . 
/
quality-control materials and pooled patients' samples (Table 1). A precision profile was also obtained by using duplicate analyses (as above, ref. 13). This gave a working range for the assay (CV <10%) of 0.13-24.0 milli-int. unitsfL. Replicate analyses of the same sample across a
Interferences
Comparison of results from the enzyme-amplified assay and the in-house RIA for samples from patients with renal disease (n = 20), liver disease (n = 21), and myeloma (n = 5) showed no deviation from the Deming regression described above.
Similarly, a comparison of results with the in-house IRMA for samples from patients with renal disease (n = 22), liver disease (n = 21), myeloma (n = 5), high bone alkaline phosphatase activity (n = 7), and lipemia (triglycerides up to 7.0 mmol/L, n = 10) showed no deviation from the above- 2)
2)
2) 2)
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